2021.02.07 14:53 GMT+8

Sinovac COVID-19 vaccine granted conditional market approval in China

Updated 2021.02.07 14:53 GMT+8
CGTN

China's National Medical Products Administration (NMPA) has granted conditional market approval to CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac Biotech. It is the second domestically developed COVID-19 vaccine to receive conditional market approval in the country.

Copyright © 

RELATED STORIES